Cleared Traditional

K143538 - MRXperion MR Injection System, MRXperion MR Injection System Syringe Kit (FDA 510(k) Clearance)

Aug 2015
Decision
242d
Days
Class 2
Risk

K143538 is an FDA 510(k) clearance for the MRXperion MR Injection System, MRXperion MR Injection System Syringe Kit. This device is classified as a Injector And Syringe, Angiographic (Class II - Special Controls, product code DXT).

Submitted by Bayer Medical Care, Inc. (Indianaola, US). The FDA issued a Cleared decision on August 14, 2015, 242 days after receiving the submission on December 15, 2014.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1650.

Submission Details

510(k) Number K143538 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 15, 2014
Decision Date August 14, 2015
Days to Decision 242 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DXT - Injector And Syringe, Angiographic
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1650